Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

TAKTAK
Showing 8 of 11 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in TAKEDA PHARMACEUTICAL CO LTD

WELLS FARGO & COMPANY/MN holds 1.1M shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), worth $21M as of 2026-Q1. The position was increased (+7.1% shares). TAK represents 0.0% of WELLS FARGO & COMPANY/MN's portfolio.

Current Value

$21M

Current Shares

1.1M

Total Value Change

+$9.8M

Total Shares Change

+264,355

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.1M
+7.1%
$21M0.0%$18.08
31
2025-Q4
Increased
1.1M
+2.5%
$16.5M0.0%$15.63
29
2025-Q3
Increased
1M
+2.1%
$15.1M0.0%$14.62
29
2025-Q2
Increased
1M
+4.7%
$15.7M0.0%$15.10
30
2025-Q1
Increased
967,827
+12.1%
$14.4M0.0%$14.71
31
2024-Q4
Decreased
863,678
-11.7%
$11.4M0.0%$12.87
0
2024-Q3
Increased
978,002
+12.2%
$13.9M0.0%$13.89
31
2024-Q2
Increased
871,667
+2.4%
$11.3M0.0%$12.36
28

Other major holders of TAK: GLENVIEW CAPITAL MANAGEMENT, LLC, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used